Background
==========

The reduction of isoflavones **1**has been actively studied during the last twenty years, owing to the range of interesting biological effects \[[@B1]-[@B3]\] -- estrogenic activity, promise in cancer, osteoporosis, and coronary heart disease prevention -- shown by the isoflavones themselves and their reduced metabolites. There are some reports \[[@B4]-[@B8]\] of total syntheses of reduced isoflavonoid structures from commercially available starting materials but overall yields in these multistep procedures tend to be low, and free hydroxy groups are not compatible. Another strategy involves the hydrogenation of isoflavones using a palladium or platinum catalyst but mixtures of reduction products are often formed \[[@B9],[@B10]\]. Certain hydride reagents have been tested, as discussed below, for the reduction of simple or protected isoflavones but many of the early results are contradictory or rely on indeterminate product characterization.

The reduction of simple (nonflavonoid) β-alkoxy-α,β-unsaturated ketones by hydride reagents (NaBH~4~, LiAlH~4~, DIBAH) occurs normally by 1,2-attack, this being a key step in the well known \"carbonyl transposition\" of 1,3-diketone enol ethers into enones (R^3^O-CR=CR^1^-COR^2^→ R-CO-CR^1^=CHR^2^). \[[@B11]-[@B15]\] Prior to our work there were no reports on the reduction of isoflavones containing free hydroxy groups which nevertheless are common, usually at one or several of the C-5, C-7 and C-4\' sites, in the naturally occurring isoflavonoids. It is to be expected that the presence of the phenolic hydroxyls, or the derived phenolate anions, will alter the reactivity pattern of the parent isoflavone system, besides perhaps decreasing the overall reactivity due to solubility reasons. For example, any tendency of hydride attack at the C-2 will be opposed by electron feeding from the 4\'-OH group while an OH group at C-5 or C-7 will discourage attack at C-2 and C-4. Thus there was ample room for the development of reliable methods for the synthesis of hydroxy-substituted isoflavone metabolites, and for clarification of the course of reduction of isoflavones with various hydride reducing agents. We present here experimental details of our own results in this field together with a thorough survey of the literature. The discussion is based on the types of reduced isoflavonoid structures formed (Figure [1](#F1){ref-type="fig"}), i.e., isoflavanones **2**, *cis*-isoflavan-4-ols **3**, *trans*-isoflavan-4-ols **4**, the ring opened α-methyldeoxybenzoins **5**and 1,2-diaryl-2-propen-1-ols **6**, and isoflavenes **7**and **8**(hydride reductions do not lead to isoflavans **9**, which however are obtained by catalytic hydrogenation \[[@B10],[@B16],[@B20]\]). Incidentally, it is appropriate to point out that flavones do not undergo similar reductive metabolism in mammals as described above for isoflavones. We will nevertheless present at a later date certain findings on the hydride reduction pathways in flavones.

![Isoflavonoid subclasses.](1860-5397-2-16-1){#F1}

Results and Discussion
======================

Isoflavanones (2)
-----------------

Isoflavanones result from the 1,4-reduction of isoflavones. The resonance contributor **10**will encourage this mode of attack. DIBAH, normally a preferential 1,2-reducer, reacts with methoxy-, benzyloxy-, MOMO- and MEMO-substituted isoflavones to give the isoflavanones in 40--93% yield \[[@B16],[@B21]-[@B23]\] (Table [1](#T1){ref-type="table"}). Our own work has shown that even *unprotected*hydroxy-substituted isoflavones are reduced by a large excess of DIBAH in 50--70% yield (Table [1](#T1){ref-type="table"}). The simple borohydride reagents reduce isoflavones to the isoflavanols (see below) but the Selectrides^®^give 60--88% yields of isoflavanones in the absence of hydroxy substituents according to our results (Table [1](#T1){ref-type="table"}). There is no significant difference between the K- and L-Selectride^®^. In the literature, there is an isolated report of the reduction of a MOM substituted isoflavone by L-Selectride^®^in 40% yield (Table [2](#T2){ref-type="table"}) \[[@B16]\]. Methoxy substituted isoflavones have also been reduced by sodium hydrogen telluride to give isoflavan-4-ones in 61--71% yields \[[@B24]\].

###### 

Reduction of isoflavones to isoflavanones.^a^

  -------- -------- -------- -------- -------- ------ ------ ------ ------ ------------- ---------
  R^2\'^   R^3\'^   R^4\'^   R^5\'^   R^6\'^   R^5^   R^6^   R^7^   R^8^   reductant,\   yield\
                                                                           eqs           %

                                                                                         

                                                                           DIB^b^, 4     72

                                                                           SEL^c^, 4     96

                                                             OH            DIB, 10       68

                                                                           SEL, 8        0

                                                             OMe           DIB, 2.5      90^d,e^

                                                                           DIB, 6        57

                                                                           SEL, 4        84

                                               Me            OMe    OMe    DIB, 2.5      75^e^

                                               OMe    OMe    OMe           DIB, 2.5      89^e^

                    OMe                                      OMe    OMe    NaHTe, 2      68^f^

                    OH                                       OH            DIB, 25       70

                                                                           SEL, 8        0

                    OMe                                      OH            DIB, 25       60

                    OMe                                      OMe           DIB, 2.5      87^e^

                                                                           DIB, 7        54

                                                                           NaHTe, 2      61^f^

                                                                           SEL, 4        82

                    OMOM                                     OMOM          DIB, 4.7      93^g^

                    OH                         OH            OH            DIB, 25       50

                                                                           SEL, 9        0

                    OMe                        OH            OH            DIB, 25       57

           OMe      OMe                               OMe    OMe           NaHTe, 2      71^f^

  OMOM              OMOM                                     OMOM          DIB, 4.7      87^g,h^

                                                                           SEL, 2        40^g^

  OMe      OMe      OBn                                      OBn           DIB, 2.5      40^i^

  OBn      OMe      OMe                                      OMe           DIB, 2.5      56^e^

  OBn      OBn      OMe      OMe                             OMe           DIB, 1.9      52^j^

  OBn      OBn      OBn               OMe                    OMe           DIB, 1.9      57^j^

  OBn      OBn      OMe      OMe                             OMe    OBn    DIB, 1.9      67^j^

  OBn      OMe      OMe                                      OMe    OBn    DIB, 1.9      61^j^

  OBn      OBn      OBn               OMe                    OMe    OBn    DIB, 1.9      58^j^
  -------- -------- -------- -------- -------- ------ ------ ------ ------ ------------- ---------

^*a*^Only substituents other than H are shown in the Table. Items without a reference are results reported here for the first time. ^*b*^DIB = di-isobutylaluminiumhydride. ^*c*^SEL = K- or L-Selectride^®^. ^*d*^2-Methyl-7-methoxyisoflavone reacted similarly in 63% yield.\[21\] ^*e*^Ref. 21. ^*f*^Ref. 24. ^*g*^Ref. 16. ^*h*^The corresponding tris(methoxyethoxymethoxy)flavone reacted similarly. ^*i*^Ref. 23. ^*j*^Ref. 22.

###### 

Reduction of isoflavones to isoflavan-4-ols^*a*^

  -------- ------ -------- -------- ------ ------ ------ -------------------------------- -------------- ----------- -----------
  SM       R^2^   R^2\'^   R^4\'^   R^6^   R^7^   R^8^   reductant, eqs, solvent          yield\         **3:4**\    Yld**6**\
                                                                                          **3**+**4**\   ratio       %
                                                                                          %                          

                                                                                                                     

  **1a**                                                 NaBH~4~,2.5,EtOH                 86             70:30       12

                                                         LiBH~4~,2.5,THF                  56             80:20       40

                                                         NaBH~4~,2.5,MeOH                 57^b^          **3**only   

                                                         NaBH~4~,2,EtOH                   75^c,d^                    

                                                         NaBH~4~,2,diglyme                88^d,e^                    

                                                         NaBH~4~,3.5,PdCl~2~,aq. THF      85             82:18       

                                                         NaBH~4~,H~3~BO~3~,2.5, EtOH      98             71:29       

                                                         NaBH~4~,CeCl~3~,1.0, DMSO        99             **3**only   

                                                         NaBH~4~,AlCl~3~,excess., digl.   81^d^                      

                                                         Zn(BH~4~)~2~,4,Et~2~O            69             62:38       19

                                                         LiEt~3~BH,4,THF                  50             70:30       

                                                         B~2~H~6~, excess,THF             76^c,d^                    

  **1b**                                   OMe           NaBH~4~,2.5,EtOH                 90             70:30       9

                                                         NaBH~4~,H~3~BO~3~,3.1, EtOH      80^f^          **3**only   

                                                         NaBH~4~,H~3~BO~3~,2.5, EtOH      97             70:30       

                                                         NaBH~4~,CeCl~3~,1.5, DMSO        88             **3**only   12

                                                         LiBH~4~,10,THF                   54             70:30       37

                                                         LiEt~3~BH,4,THF                  55             65:35       

  **1c**                   OMe             OMe           NaBH~4~,2.5,MeOH                 37^b^          3 only      

                                                         NaBH~4~,2.5,EtOH                 88             70:30       10

                                                         NaBH~4~,CeCl~3~,2.5, DMSO        86             3 only      10

                                                         NaBH~4~,H~3~BO~3~,2.5, EtOH      96             70:30       

                                                         LiBH~4~,10,THF                   70             77:23       10

                                                         Zn(BH~4~)~2~,2,Et~2~O            74             62:38       

                                                         LiEt~3~BH,4,THF                  36             78:22       

  **1**           OMOM     OMOM            OMOM          NaBH~4~,15.9,EtOH, THF\          87^g^\         65:35\      
                                                         LiBH~4~,10,THF                   82^g^          57:43       

  **1**    Me                       Br     OMe           NaBH~4~,4.2,EtOH                 25^e,h^                    

  **1**    Me                       Br     OBn           NaBH~4~,4.2,EtOH                 22^e,h^                    

  **1**    Me                              OMe    Br     NaBH~4~,4.2,EtOH                 20^e,h^                    

  **1**    Me                       Br     OMe    Br     NaBH~4~,4.2,EtOH                 20^e,h^                    
  -------- ------ -------- -------- ------ ------ ------ -------------------------------- -------------- ----------- -----------

^*a*^Only substituents other than H are shown. According to our results, OH substituted isoflavones are not reduced, nor are such reactions reported in the literature. Items without a reference are results reported here for the first time. ^*b*^Ref. 25. ^*c*^Product was given as 2-isoflaven-4-ol. ^*d*^Ref. 28. ^*e*^Product ratio not given. ^*f*^Ref. 26. ^*g*^Ref. 16. ^*h*^Ref. 27.

Isoflavanols (3, 4)
-------------------

Full reduction at the heterocyclic ring of isoflavones by LiBH~4~or NaBH~4~leads to isoflavanols in 20--91% yield (Table [2](#T2){ref-type="table"}), \[[@B16],[@B25]-[@B28]\]except with hydroxy substituted substrates which do not react at all. Apparently the first step involves a 1,4-addition to give the isoflavanone enolate which picks up a proton from the solvent and is reduced further to the saturated alcohol. There are no reports of the intermediacy of the alternative 1,2-reduction products, the allylic alcohols **11**which in fact appear very incompletely known in the chemical literature (see below). Similarly, the reduction of isoflavanones **2**by LiBH~4~, NaBH~4~, L-Selectride^®^or Li(*t*-BuO)~3~AlH gives mixtures of *cis*-**3**and *trans*-isoflavan-4-ols **4**(Table [3](#T3){ref-type="table"}). \[[@B16],[@B29],[@B34]\] Isoflavanones are reduced by electrophilic hydrides (borane-tetrahydrofuran, bis-*tert*-butylthioethane borane) diastereoselectively to *cis*-isoflavan-4-ols, but a large excess of the reducing agent is usually needed \[[@B29]\].

###### 

Reduction of isoflavanones to isoflavan-4-ols^*a*^

  -------- -------- -------- -------- -------- ------------------------- ---------- ------------
  SM       R^2\'^   R^3\'^   R^4\'^   R^7^     reductant, eqs, solvent   yield\     **3:4**\
                                                                         **3+4**%   ratio

                                                                                    

  **2a**                                       NaBH~4~, ng.,EtOH\        99^b^\     70:30\
                                               NaBH~4~,2,MeOH,THF\       99^c^\     42:58\
                                               Li(t-BuO)~3~AlH,10,THF\   99^c^\     34:66\
                                               B~2~H~6~,80,THF           98^c^      **3**only

  **2b**                              OMe      NaBH~4~,2,MeOH,THF\       99^c^\     44:56\
                                               NaBH~4~,1.2,EtOH\         67^d^\     67:33\
                                               Li(t-BuO)~3~AlH,10,THF\   99^c^\     33:67\
                                               L-Selectride, ng\         99^c^\     37:63\
                                               B~2~H~6~,80,THF\          99^c^\     **3**only\
                                               BTED^g^,0.7,THF           98^c^      **3**only

  **2**                      OH       OH       LiBH~4~,6.9,THF           94^e^      70:30

  **2**                      OTBDMS   OTBDMS   LiBH~4~,2,THF             96^f^      70:30

  **2c**                     OMe      OMe      NaBH~4~,2,THF,MeOH\       99^c^\     43:57\
                                               NaBH~4~,1.2,EtOH\         50^d^\     **3**only\
                                               Li(t-BuO)~3~AlH,10,THF\   99^c^\     34:66\
                                               B~2~H~6~,80,THF           97^c^      **3**only

                                               BTED^g^,0.7,THF           97^c^      **3**only

  **2**             OMe      OMe      OMe      NaBH~4~,2,THF,MeOH        99^c^      36:64

                                               Li(t-BuO)~3~AlH,10,THF    99^c^      32:68

                                               B~2~H~6~,80,THF           98^c^      **3**only

                                               BTED^g^,0.7,THF           98^c^      **3**only

  **2**    OMOM              OMOM     OMOM     LiBH~4~,10,THF            73^h^      55:45

                                               LiAlH~4~,17,THF           78^h^      45:55

                                               NaBH~4~,15.9,THF,MeOH     91^h^      70:30
  -------- -------- -------- -------- -------- ------------------------- ---------- ------------

^*a*^Only substituents other than H are shown. ng not given ^*b*^Ref. 31. ^*c*^Ref. 29. ^*d*^Ref. 30. ^*e*^Ref. 32. ^*f*^Ref. 33. ^*g*^bis-*t*-butylthioethane diborane. ^*h*^Ref. 16.

Although it was realized by the early workers that diastereomeric mixtures of isoflavanols would presumably be formed, there were no reliable methods to determine their structures. In some papers, the products are summarily assigned the *cis*\[[@B25],[@B26]\] or *trans*\[[@B35]-[@B38]\] structures. However, rigorous NMR analysis has recently made it possible to establish *cis*- and *trans*-structures for the isoflavanol products and to study their conformational equilibria \[[@B32],[@B34]\]. Borohydride reductions generally give a small preference for the *cis*products as suggested by Cram\'s rule \[[@B39]\]. We are not aware of any examples in the literature of single enantiomers of isoflavanone or isoflavanol metabolites, nor have such compounds been reported as hydride reduction products of isoflavones. In view of the significant biological properties of the reduced metabolites it will be interesting to examine the behaviour of the pure enantiomers.

2-Isoflaven-4-ols (11)
----------------------

There are very few reports of this class of compounds, either from reductive processes or otherwise. In 1965, the reduction of the parent isoflavone by NaBH~4~in EtOH or diborane in THF was claimed \[[@B28]\] to furnish 2-isoflaven-4-ol in 75--76% yield, but unfortunately the characterization of this product relied on elemental analysis only. More recently, Japanese workers \[[@B40]\] reported that the reduction of **12**(Figure [2](#F2){ref-type="fig"}) by NaBH~4~in the presence of PdCl~2~in THF-H~2~O gave a 1:1 mixture of the ketone **13a**and the diol **13b**(Figure [2](#F2){ref-type="fig"}). A ^1^H NMR spectrum was given for the latter isoflavenol but there appear to be certain discrepancies, notably in the δ value (8.69) reported for the H-8 which is some 2 δ units in excess of what would be expected for such a vinyl ether proton. Thus more work is required to fully confirm the nature of this class of reduction products. In the event, in our studies the reduction of isoflavone **1a**by NaBH~4~in the presence of PdCl~2~in THF-H~2~O gave a 82:18 mixture of *cis*- and *trans*-isoflavan-4-ol **3a**, **4a**while no 2-isoflaven-4-ols were observed. The absence of such 1,2-reduction products, or structures conceivably derivable thereof such as 2- or 3-isoflavenes (**7**, **8**), even in the CeCl~3~-complexed NaBH~4~reductions, must reflect the good stabilization obtainable via resonance heteroring stabilization (**10**) in the isoflavones. As already mentioned, this is in contrast to the behaviour of simple non-flavonoid β-alkoxy-α,β-unsaturated ketones which prefer 1,2-attack by hydride.

![2-Isoflaven-4-ols and 1-(2-hydroxyphenyl)-2-phenyl-2-propen-1-one](1860-5397-2-16-2){#F2}

Isoflavenes (7, 8) and isoflavans (9)
-------------------------------------

In the early work, \[[@B41]\] there is a mention of 7,4\'-dimethoxy-2-methyl-3-isoflavene being obtained in 15% yield from the reduction of the corresponding isoflavone by LiAlH~4~in Et~2~O-benzene but there is no structural data on the product other than elemental analysis, itself quite accurate. Similarly 2\',4\'-dimethoxy-3\',6,7-trihydroxyisoflav-3-ene was reported from the reduction of 2\',4\'-dimethoxy-3\',6,7-trihydroxyisoflavan-4-one with LiAlH~4~in low yield \[[@B42]\]. More recent work by us \[[@B43]\] and others \[[@B16],[@B44]\] would indicate that the normal course of LiAlH~4~reduction of isoflavones leads to deoxybenzoins and propenols (see below and Table [4](#T4){ref-type="table"}).

###### 

Reduction of isoflavones to α-methyldeoxybenzoins and 1,2-diaryl-2-propen-1-ols^*a*^

  -------- -------- ------ ------ ------------------------- ----------- ----------
  R^2\'^   R^4\'^   R^5^   R^7^   reductant, eqs, solvent   yield (%)   
                                                            of **5**    of **6**
                                                                        
                                  LiAlH~4~, 2.5,THF         27^b^       48
                                  Li(t-BuO)~3~AlH, 5,THF    74          6
                                  Red-Al, 2.5,THF           12          50
                                  LiBH~4~, 10, THF          9           68
                           OMe    LiAlH~4~, 2.5,THF         29^b^       50
                                  LiAlH~4~, 1, THF          62^c^       \-
                                  Li(t-BuO)~3~AlH,10,THF    88          12
                                  LiBH~4~, 10, THF          7           37
           OMe             OMe    LiAlH~4~,3.3,THF          27^b^       70
                                  Li(t-BuO)~3~AlH,10,THF    88          12
                                  LiBH~4~, 10, THF          5           10
                           OH     LiAlH~4~,3.3,THF          60^b^       \-
                                  Li(t-BuO)~3~AlH,8,THF     \-          \-
           OH              OH     LiAlH~4~,5.5,THF          42^b^       \-
                                  Li(t-BuO)~3~AlH,10,THF    \-          \-
           OMe             OH     LiAlH~4~,3.3,THF          42^b^       \-
           OH       OH     OH     LiAlH~4~,5.5,THF          66^b^       \-
           OMe      OH     OH     LiAlH~4~,4.3,THF          70^b^       \-
           OH              OMe    LiAlH~4~,3.3,THF          17^b^       34
  OMOM     OMOM            OMOM   LiAlH~4~,7.9,THF          6^d^        \-
  -------- -------- ------ ------ ------------------------- ----------- ----------

^*a*^Only substituents other than H are shown in the Table. Items without a reference are results reported here for the first time. ^*b*^Ref. 43. ^*c*^Ref. 44. ^*d*^Ref. 16.

**a**all R groups = H

**b**R^7^= Me, other R groups = H

**c**R^4^= R^7^= Me, other R groups = H.

Published syntheses of 2- and 3-isoflavenes involve the reduction of 3-arylcoumarins, \[[@B45]-[@B47]\] the corresponding aldehyde hemiacetals, \[[@B7]\] isoflavylium salts \[[@B48]-[@B50]\] or of isoflavones by the Clemmensen reaction \[[@B51]\]. Low-yielding non-reductive routes to 2- and/or 3-isoflavenes have also been reported \[[@B52],[@B53]\]. 2-Isoflavenes **7**however remain mostly poorly characterized, and some of the NMR spectral details reported \[[@B7],[@B51],[@B52]\] appear inconsistent with the 2-isoflavenoid structure. As far as the NMR spectra of 2-isoflavenes are concerned, a recent study clears this issue by 2D NMR work on a natural 2-isoflavene, \[[@B54]\] establishing that the H-2 and H-4 protons appear at δ 6.87 and 3.61, respectively, much as expected by correlation data shift calculations. Isoflavans (**9**) have not been prepared by hydride reductions, but by catalytic hydrogenation of isoflavones \[[@B10],[@B16]-[@B20]\].

Deoxybenzoins (5) and propenols (6)
-----------------------------------

Isoflavanones undergo a facile retro-Michael-type ring opening \[[@B21],[@B55]\] under basic conditions to give the propenone intermediate **14**(Figure [2](#F2){ref-type="fig"}), sometimes considered \[[@B56]\] to be an independent isoflavone metabolite but presumably just an artefact in reality. As regards the synthesis of isoflavanones by DIBAH reduction of isoflavones (see above), we found that unless the workup is done with cold methanolic HCl, some amount of the propenone **14**will be formed and reduced further to the deoxybenzoin **5**. If on the other hand the deoxybenzoins are the actual synthetic targets, the reducing agent of choice is LiAlH~4~in THF. This works very well for isoflavones bearing a hydroxy group at C-7 such as genistein, but in isoflavones lacking a 7-OH group another reaction pathway competes leading to the propenols **6**\[[@B43]\] as byproducts (see below). We have discussed a possible mechanism to explain these hydroxyl-dependent divergent pathways \[[@B43]\].

To summarize, all hydride addition reactions with isoflavones appear to involve an initial 1,4-addition to give the isoflavanone enolate. In a hydroxylic solvent, or even on workup under basic conditions, the ketone is generated, and reduced further to the saturated alcohol (NaBH~4~). In a nonprotic solvent, the β-aryloxyenolate will undergo a retro-Michael addition, giving the phenolate anion of the ring opened 2-propen-1-one which may undergo a 1,2- or 1,4-addition of hydride (LiAlH~4~, LiBH~4~). If the *O*-metal bond in the initial enolate is very tight, the ring opening does not occur and allows the isolation of the isoflavanone (DIBAH, Selectrides^®^). The presence and number of hydroxy or alkoxy substituents in the substrates does not have a major effect in these reductions except in the case of NaBH~4~reduction which fails completely presumably due to solubility reasons, and the LiAlH~4~reduction where the outcome depends on the presence or absence of an OH group at C-7. Based on our and previous results by other workers, the reducing agents of choice for the synthesis of reduced isoflavonoids are as follows:

isoflavanones (**2**) from non-hydroxylated isoflavones DIBAH or Selectrides^®^

isoflavanones (**2**) from hydroxylated isoflavones DIBAH

*cis*-isoflavanols (**3**) from non-hydroxylated isoflavones NaBH~4~/CeCl~3~

*cis*-isoflavanols (**3**) from hydroxylated isoflavones no good methods

*cis*-isoflavanols (**3**) from non-hydroxylated isoflavanones B~2~H~6~or BTED

*trans*-isoflavanols (**4**) from isoflavones no good methods

*trans*-isoflavanols (**4**) from isoflavanones Li(*t*-BuO)~3~AlH

2-isoflaven-4-ols (**11**) from isoflavones uncertain

isoflavenes (**7**, **8**) from isoflavones Clemmensen

isoflavans (**9**) from isoflavones H~2~, Pd/BaSO~4~

α-methyldeoxybenzoins (**5**) from non-hydroxylated isoflavones Li(*t*-BuO)~3~AlH

α-methyldeoxybenzoins (**5**) from hydroxylated isoflavones LiAlH~4~

1,2-diaryl-2-propen-1-ols (**6**) from non-hydroxylated isoflavones LiBH~4~or LiAlH~4~

Conclusion
==========

Dietary isoflavonoids in vegetables, beans, peas and other legumes are possible cancer preventing agents, particularly in hormone based cancers such as breast and prostate cancer. \[[@B57]-[@B59]\] Epidemiological studies have shown that they decrease the risk of colon cancer, osteoporosis, and coronary heart disease. \[[@B1]-[@B3]\] Significantly, health claims of soy foods, rich in isoflavonoids, have recently received FDA authorization \[[@B60]\].

The dietary isoflavonoids are mainly metabolized in man via reductive pathways, leading to the reduced structural types discussed above (Figure [3](#F3){ref-type="fig"}). These compounds are often more estrogenic than the starting isoflavones. Research interest in many fields including medicine, nutrition and biosynthesis and metabolism thus converge on the reduced isoflavonoids. The work described in this paper shows that most structural types of reduced isoflavonoids are now reliably available in satisfactory or good yields by hydride reductions. Although not discussed here, it is clear that D atoms may be introduced in the same way which is very useful in the quantitation of the naturally occurring compounds by GC-MS selected ion monitoring techniques \[[@B61]\].

![Dietary isoflavones and their metabolites in humans.\
**e** R^4'^=OMe, R7= OH, other R groups = H\
**f** R^4'^= OMe, R5=R7= OH, other R groups = H\
**g** R^4'^= R5=R7= OH, other R groups = H\
**h** R^4'^=R7= OH, other R groups = H\
**i** R^4'^=R7= OH, R6=OCH3, other R groups = H\
**j** R^4'^= R6=R7= OH, other R groups = H\
**k** R^3'^= R7= OH, other R groups = H\
**l** R^3'^=R4'=R7= OH, other R groups = H](1860-5397-2-16-3){#F3}
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